TCTR20230719003尚未招募1 期
Bioequivalence study of empagliflozin 25 mg film-coated tablet in Thai healthy volunteers
Macrophar Co., Ltd.0 个研究点目标入组 28 人开始时间: 2023年7月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy Thai Volunteers
排除标准
- •Subjects who are with a history/evidence of drug sensitivity or allergic reaction to empagliflozin, or any related drug. Subjects who are positive for COVID-19 test.
研究者
相似试验
尚未招募
1 期
Bioequivalence study of empagliflozin 25 mg film-coated tablet in Thai healthy volunteersThai healthy male and female subjects , Aged 18 to 55 years , BMI were within 18-30 kg/m2 , Good health confirming by physical and clinical.Empagliflozin, Bioequivalence studyTCTR20230711001Faculty of Medicine, Chulalongkorn University28
招募中
Unknown
Bioequivalence study of Empagliflozin 25 mg tabletIRCT20200105046010N83kharazmi company24
招募中
不适用
Bioequivalence of EmpaglifloziDetermination of plasma concentration of Empagliflozin 25 mg pharmaceutical product.IRCT20210201050197N5Shahid Beheshti University of Medical Sciences24
已完成
1 期
Bioequivalence of Empagliflozin 25 mg FCT in Healthy Thai volunteersBioequivalence study of 25 mg empagliflozin FCTTCTR20210324005nison Laboratories Co., Ltd.28
尚未招募
不适用
Bioequivalence study of Empagliflozin 12.5 mg+ Metformin 1000 mg in 24 healthy male under fasting conditionsIRCT20180620040164N13ACtover Pharmaceutical Co26